Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Howard University has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions involve 4 distinct examiners and are spread across 3 distinct art units. HAGOPIAN, CASEY SHEA is the busiest examiner, handling 1 busiest examiner pending action.
This indicates that the examiners are concentrated within 3 art units for their pharmaceutical filings. The distribution suggests a varied but somewhat localized prosecution effort for the university's current biotechnology innovations.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGOPIAN, CASEY SHEA | 1 | 54.3% | +33.4% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.8% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| BARRERA, IMMACULADA | 1 | 30.0% | +80.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 26d overdue |
| 18173264 | VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES | BRADLEY, CHRISTINA | 75d |
| 18959847 | POLYSACCHARIDE-POLYAMINE COPOLYMERS FOR REMOVAL OF PHOSPHATE | HAGOPIAN, CASEY SHEA | — |
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | — |
| Art Unit | Apps |
|---|---|
| 1617 | 2 |
| 1654 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959847 | POLYSACCHARIDE-POLYAMINE COPOLYMERS FOR REMOVAL OF PHOSPHATE | HAGOPIAN, CASEY SHEA | 1617 | §103DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | 1617 | DP | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18173264 | VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES | BRADLEY, CHRISTINA | 1654 | §103 | Final Rejection | 75d | Pending | Feb 23, 2023 |
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 1671 | §101§103§112 | Final Rejection | 26d overdue | Pending | Nov 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHoward University has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Casey Shea Hagopian has the most, with 1 of Howard University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
